These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3592858)

  • 21. Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin.
    Lautenslager GT; Shearman CW; Hud E; Cohen MP
    Metabolism; 2011 Dec; 60(12):1683-91. PubMed ID: 21632076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site I on human albumin: differences in the binding of (R)- and (S)-warfarin.
    Bertucci C; Canepa A; Ascoli GA; Guimaraes LF; Felix G
    Chirality; 1999; 11(9):675-9. PubMed ID: 10506426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New aspects of free drug concentration determination in human serum with equilibrium dialysis.
    van der Giesen WF; Wilting J
    Methods Find Exp Clin Pharmacol; 1982; 4(6):417-23. PubMed ID: 7144334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a perfluorochemical emulsion on prednisolone binding by human albumin.
    Parsons DL
    Biochem Pharmacol; 1986 Apr; 35(8):1395-7. PubMed ID: 3964304
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of a new perfluorocarbon emulsion on human plasma and whole-blood viscosity in the presence of albumin, hydroxyethyl starch, or modified fluid gelatin: an in vitro rheologic approach.
    Jouan-Hureaux V; Audonnet-Blaise S; Lacatusu D; Krafft MP; Dewachter P; Cauchois G; Stoltz JF; Longrois D; Menu P
    Transfusion; 2006 Nov; 46(11):1892-8. PubMed ID: 17076843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increases in brain tumor and cerebral blood flow by blood-perfluorochemical emulsion (Fluosol-DA) exchange.
    Hiraga S; Klubes P; Owens ES; Cysyk RL; Blasberg RG
    Cancer Res; 1987 Jun; 47(12):3296-302. PubMed ID: 3581070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosage plan of a flurbiprofen injection product using inhibition of protein binding by lipid emulsion in rats.
    Ogata K; Takamura N; Tokunaga J; Kawai K; Arimori K; Higuchi S
    J Pharm Pharmacol; 2008 Jan; 60(1):15-20. PubMed ID: 18088500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of palmitate and oleate on the binding of warfarin to human serum albumin: stopped-flow studies.
    Rietbrock N; Menke G; Reuter G; Lassmann A; Schmeidl R
    J Clin Chem Clin Biochem; 1985 Nov; 23(11):719-23. PubMed ID: 4086977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
    Urien S; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):319-25. PubMed ID: 6790449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QCM/HCC as a platform for detecting the binding of warfarin to an immobilized film of human serum albumin.
    Zilberman G; Smith AL
    Analyst; 2005 Nov; 130(11):1483-9. PubMed ID: 16222368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE.
    Rich RL; Day YS; Morton TA; Myszka DG
    Anal Biochem; 2001 Sep; 296(2):197-207. PubMed ID: 11554715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro effect of Cl2Ca and Cl2Mg on warfarin-human serum albumin (HSA) binding.
    Pérez Gallardo L
    Magnes Res; 1999 Mar; 12(1):43-8. PubMed ID: 10192099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infusion of albumin attenuates changes in serum protein binding of drugs in surgical patients compared with volume replacement with HAES.
    Reine PA; Kongsgaard UE; Andersen A; Thøgersen AK; Olsen H
    Acta Anaesthesiol Scand; 2008 Mar; 52(3):406-12. PubMed ID: 18269390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of propofol to human serum albumin.
    Schywalsky M; Ihmsen H; Knoll R; Schwilden H
    Arzneimittelforschung; 2005; 55(6):303-6. PubMed ID: 16032968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the N-B transition of human serum albumin on the structure of the warfarin-binding site.
    Kasai-Morita S; Horie T; Awazu S
    Biochim Biophys Acta; 1987 Sep; 915(2):277-83. PubMed ID: 3651475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorocarbon aerosol propellants V: binding interaction with human albumin.
    Chiou WL; Hsiao JH
    J Pharm Sci; 1975 Jun; 64(6):1052-4. PubMed ID: 1133731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ethanol on the binding of warfarin enantiomers to human serum albumin.
    Tatsumi A; Kadobayashi M; Iwakawa S
    Biol Pharm Bull; 2007 Apr; 30(4):826-9. PubMed ID: 17409531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of competitive displacement agents to resolve albumin binding problems observed during the development of a radioimmunoassay for ICI 215001.
    Ballard P; Malone MD; Law B
    J Pharm Biomed Anal; 1994 Jan; 12(1):47-52. PubMed ID: 7909237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin binding to plasma albumin, measured in patients and related to fatty acid concentrations.
    Larsen FG; Larsen CG; Andersen S; Nørgaard A; Hansen HE; Brodersen R
    Eur J Clin Invest; 1986 Feb; 16(1):22-7. PubMed ID: 3084268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.